It is estimated that the stem cell industry could produce billions of dollars of revenues per year upon gaining approvals by the U.S. FDA.
Globally, as safety and effectiveness have been demonstrated, many clinicians utilize stem cell therapy outside of the United States. Medistem (MDSM), is licenseing international medical facilities, to enable safe and standardized stem cell therapies.
Let us hear your thoughts below: